Physician profile
Dorothy Min
NPI 1548267974
$1,949.67
in general payments reported to CMS, 2019-2025
17 companies · $707 in 2025
The $707 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.16 · 2020: $148 · 2021: $53.07 · 2022: $108 · 2023: $341 · 2024: $531 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,579.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $477.79 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $472.48 | 2021-2025 | |
| Organon LLC | $265.97 | 2022-2025 | Nexplanon |
| Abbvie INC. | $149.50 | 2020-2023 | |
| Coopersurgical, INC. | $111.80 | 2020-2025 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $88.81 | 2019-2024 | Gardasil 9, Gardasil |
| Biogen, INC. | $88.43 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $66.51 | 2025 | Slynd |
| Evofem Biosciences, INC. | $49.16 | 2024-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $48.54 | 2024 | Myfembree |
| Avion Pharmaceuticals | $28.79 | 2021 | |
| Millicent US INC | $23.86 | 2024 | Femring, Intrarosa |
| Vertical Pharmaceuticals, LLC | $23.23 | 2019 | |
| Pfizer INC. | $19.25 | 2024 | |
| Myovant Sciences INC. | $18.49 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.06 | 2025 | Aptima |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorothy Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.